Riskpilot← Back to searchSign inGet full accessLunds Naprapatklinik AB
ABActiveOrg 5567012942Stora Tomegatan 16 APhysiotherapy activities · NACE 8695Est. 20063 employees
Revenue 2024
SEK 4,1M
+16% vs 2023
EBITDA margin
18.2%
+80% vs 2023
Equity ratio
25.1%
Financial strength
Net profit 2024
SEK 235K
+770% vs 2023
| Revenue | SEK 4,1M | +16% |
| EBITDA | SEK 744K | +80% |
| Net profit | SEK 235K | +770% |
| Total assets | SEK 7,1M | +1% |
| Equity | SEK 1,8M | +2% |
| Employees | 3 | — |
Legal name
Lunds Naprapatklinik AB
Org number
5567012942
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
3 april 2006
Share capital
SEK 100 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva naprapatverksamhet, sociologiverksamhet, bokutgivning och äga och förvalta fast och lös egendom samt därmed förenlig verksamhet.
Address
Stora Tomegatan 16 A
Phone
+46462110605
Email
info@lundsnaprapatklinik.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 919 | 3 240 | 3 660 | 3 527 | 4 091 |
| Staff expenses | — | — | — | — | −2 135 |
| EBITDA | 366 | 734 | 635 | 414 | 744 |
| Depreciation & amort. | −80 | −81 | −102 | −137 | −91 |
| EBIT | 286 | 653 | 533 | 277 | 653 |
| Net financials | −82 | −76 | −129 | −220 | −215 |
| Profit before tax | 149 | 437 | 288 | 58 | 313 |
| Tax | −38 | −96 | −71 | −31 | −78 |
| Net profit | 111 | 341 | 217 | 27 | 235 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 694 | 6 993 | 7 203 | 7 019 | 7 088 |
| Equity | 1 731 | 1 888 | 1 918 | 1 750 | 1 780 |
| Long-term debt | 4 432 | 4 341 | 4 510 | 4 254 | 4 137 |
| Short-term debt | 375 | 468 | 364 | 606 | 636 |
| Total debt | 4 807 | 4 809 | 4 874 | 4 860 | 4 773 |
EBITDA margin
18.2%
This company
15.8%
Market median
+15% vs market
20202024
Equity ratio
25.1%
This company
38.2%
Market median
-34% vs market
20202024
Return on equity
13.2%
This company
18.4%
Market median
+28% vs market
20202024
Net profit margin
5.7%
This company
8.1%
Market median
-30% vs market
20202024
Asset turnover
0.58×
This company
1.12×
Market median
-48% vs market
20202024
Debt / equity
2.98×
This company
0.62×
Market median
-381% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JT Auditor Substitute | Auditor Substitute | 2022 |
| Audit | 2022 | |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Lunds Naprapatklinik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Tomas Ahlgren | Auditor Substitute | 0 companies |
| Åsa Cecilia Andersson Eneberg | Audit | 0 companies |
| Erik Mats Vilhelm Hannerz | Deputy Board Member | 0 companies |
| Sara Maria Hannerz | Board of Directors | 0 companies |